Acadia Healthcare Company major shareholder Jack E. Polson Unloads 4,000 Shares (ACHC)
Acadia Healthcare Company (NASDAQ:ACHC) major shareholder Jack E. Polson sold 4,000 shares of Acadia Healthcare Company stock in a transaction that occurred on Tuesday, July 29th. The shares were sold at an average price of $50.34, for a total value of $201,360.00. Following the sale, the insider now directly owns 179,823 shares in the company, valued at approximately $9,052,290. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Shares of Acadia Healthcare Company (NASDAQ:ACHC) traded up 1.33% on Wednesday, hitting $51.98. 337,116 shares of the company’s stock traded hands. Acadia Healthcare Company has a 1-year low of $36.92 and a 1-year high of $53.87. The stock has a 50-day moving average of $48.02 and a 200-day moving average of $46.22. The company has a market cap of $3.109 billion and a price-to-earnings ratio of 42.19.
Acadia Healthcare Company (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.31 by $0.01. The company had revenue of $213.80 million for the quarter, compared to the consensus estimate of $207.73 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. Analysts expect that Acadia Healthcare Company will post $1.46 EPS for the current fiscal year.
ACHC has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Acadia Healthcare Company from an “outperform” rating to a “neutral” rating in a research note on Tuesday, August 5th. They now have a $53.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of Acadia Healthcare Company from $54.00 to $58.00 in a research note on Friday, August 1st. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Acadia Healthcare Company from $57.00 to $60.00 in a research note on Thursday, July 31st. They now have a “buy” rating on the stock. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Acadia Healthcare Company has an average rating of “Buy” and a consensus target price of $53.57.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
Receive News & Ratings for Acadia Healthcare Company Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.